Results 1 to 10 of about 290,574 (147)
Acta Biochimica et Biophysica Sinica, 2023 The clinical oncogenic functions and mechanisms of activating transcription factor 1 (ATF1) in the progression of lung adenocarcinoma have not been completely elucidated.
Mei Jinhong +8 more
doaj +1 more source
Frontiers in Oncology, 2022 BackgroundThe main aim of the study was to determine the risk factors of lung adenocarcinoma and to analyze the variations in the incidence of lung adenocarcinoma according to time, sex, and smoking status in North China.MethodsPatients with lung cancer ...
Daojuan Li +5 more
doaj +1 more source
Expression of MAD2L1 in Lung Adenocarcinoma and Its Effect on Immune Microenvironment
Zhongliu Fangzhi Yanjiu, 2022 Objective To investigate the expression of MAD2L1 in lung adenocarcinoma and its effect on the prognosis and immune microenvironment of patients. Methods The difference of MAD2L1 expression in lung adenocarcinoma tissue and normal lung tissue was ...
LIU Yingbo +3 more
doaj +1 more source
High GNG4 expression is associated with poor prognosis in patients with lung adenocarcinoma
Thoracic Cancer, 2022 Background The purpose of this study was to explore the reason for guanine nucleotide binding‐protein gamma subunit‐4 (GNG4) overexpression and the relationship between GNG4 overexpression and the poor prognosis of lung adenocarcinoma (LUAD) patients ...
Bodong Zhou +7 more
doaj +1 more source
Immune Resistance in Lung Adenocarcinoma [PDF]
Cancers, 2021 Lung cancer is the leading cancer killer worldwide, imposing grievous challenges for patients and clinicians. The incidence of lung adenocarcinoma (LUAD), the main histologic subtype of lung cancer, is still increasing in current-, ex-, and even non-smokers, whereas its five-year survival rate is approximately 15% as the vast majority of patients ...
Magda Spella, Georgios T. Stathopoulos
openaire +3 more sources
World Journal of Surgical Oncology, 2022 Background Lung adenocarcinoma is the leading cause of cancer death worldwide. Recently, ubiquitin C-terminal hydrolase L1 (UCHL1) has been demonstrated to be highly expressed in many tumors and plays the role of an oncogene.
Jianbo Yao +9 more
doaj +1 more source
Translational Oncology, 2022 Objectives: ARNTL2, as a circadian transcription factor, has been recently proposed to play an important role in a variety of tumors. however, the role of ARNTL2 in lung carcinogenesis and progression remains unclear.
Huan Zhang +10 more
doaj +1 more source
Expression, prognostic value of CBX3 in lung adenocarcinoma and its effect on biological behavior of cancer cells [PDF]
Zhongguo aizheng zazhi, 2022 Background and purpose: Chromobox 3 (CBX3), an important component of chromatin, is involved in the development and progression of various cancers. However, the expression and role of CBX3 in lung adenocarcinoma are still unclear.
HOU Qinghua, ZHONG Yanfeng, LIU Linzhuang, WU Liusheng, LIU Jixian
doaj +1 more source
Discover Oncology, 2023 Enrichment of Veillonella parvula in the lung microbiota is strongly associated with non-small cell lung cancer (NSCLC) and induces the progression of lung adenocarcinoma in vivo, but its actual role and mechanism remain unexplored.
Wen Zeng +7 more
doaj +1 more source
Dermatomyositis Anteceding Lung Adenocarcinoma [PDF]
Cureus, 2020 Dermatomyositis is often presented as paraneoplastic syndrome. The diagnosis of dermatomyositis can prompt clinicians to further investigate the underlying cause, in particular malignancy. This case report illustrates the association of lung adenocarcinoma and dermatomyositis with antecedent presentation of cutaneous and musculoskeletal manifestations,
Lim, Jin Lee +3 more
openaire +2 more sources